Search results
Medicare Part D Plans Poorly Cover Adalimumab Biosimilars
Medscape· 4 days agoThis narrow coverage limits the cost-saving potential of these biosimilar competitors, expert said.
CMS Redesigns the Medicare Part D Prescription Drug Program Beginning in 2025 | JD Supra
JD Supra· 7 days agoThe Final Program Instructions reflect a newly defined standard Part D benefit design through several changes or enhancements to the Part D program beginning in 2025. Of those changes or enhancements ...
TONI SAYS: Enrolling in Medicare over 65 with health issues
The Weatherford Democrat· 9 hours agoWhat should I do to prepare for this medical insurance change? When we meet with clients during a Toni Says Medicare consultation, we emphasize that “Medicare< ...
State Retiree Health Plans Switching to Medicare Advantage
TheStreet.com· 3 days agoMedicare Advantage is on the rise, but is it right for you? Jae Oh explains why many states are making the switch and shaking up their retiree health plans ...
Humira Clobbers Biosimilars in Battle for Part D Coverage
MedPage Today· 4 days agoJust about every Medicare Part D prescription drug plan on offer this year covers the original version of adalimumab (Humira), whereas ...
Amarin's Vascepa to Be Dropped From Coverage by National Pharmacy Benefit Manager
Market Watch· 6 days agoThe PBM said it will be transitioning Vascepa to not covered as of July 1. Currently, Vascepa's volume through these formularies represents about 25% of U.S. prescription volume. Amarin said ...
Janie Slaven: TONI SAYS: What's the difference between in home health care and at-home?
The Times-Tribune, Corbin, Ky. via Yahoo News· 2 days agoJun. 7—Dear Toni, I need your help regarding my parents who are in their late 80s. My mother has been disabled with Parkinson's for the past 3 years and my father has been her caretaker, but ...
Why South Dakota health care is the nation’s second most expensive
South Dakota Searchlight via Yahoo News· 14 hours agoSeveral months ago, Forbes, a respected business and economics publication, released an analysis of...
What to know when enrolling in Medicare after age 65 with health issues
Las Vegas Review-Journal· 3 days agoHer cancer treatment drugs are expensive, and I am concerned about the Medicare Part D out-of-pocket...
RBC maintains Perform rating on Neurocrine Bio shares By Investing.com
Investing.com· 4 days agoOn Thursday, RBC (TSX:RY) Capital maintained its Sector Perform rating on Neurocrine (NASDAQ:NBIX)...